MicroByre
About MicroByre
MicroByre is a platform for bacterial domestication. Their automated characterization pipeline gathers the oft-overlooked data that highlights unleveraged bacteria that meet functional industrial criteria. That is, they rapidly find the bacteria with naturally unfussy eating habits and evolution-honed metabolisms that have the potential to convert unrefined biomasses into commodity chemicals at vastly improved efficiencies compared to extant fermentation processes. They select from these functionally de-risked bacteria those which can be directly genetically modified to improve their cost profiles — even if they have never been engineered before. The data from our unique characterization pipeline informs the minimally precise genetic modifications necessary to increase pliability and yield, eliminate nutritional additives, maximize feedstock utilization, and improve contamination tolerance & phage resistance. MicroByre gives biomass conversion a truly competitive edge against petrochemical synthesis. MicroByre’s platform bridges the gap between the promising and the profitable in synthetic biology and bioengineering. A unique combination of resources and skills makes MicroByre a valuable potential partner for companies of all sizes and industries. They collaborate to define project scope to match a mutually agreeable business model, which could be a fee for service, license agreement, or joint development agreement.
Company Metrics
- Employees: 1-10
- Monthly Visits: 7564
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 16197892 USD
- Last Funding: None (Series A)
- Funding Status: Early Stage Venture
Technology Stack
MicroByre actively uses None products in their tech stack.
Market Presence
Industries: Bioinformatics, Biotechnology, Genetics
Headquarters: San Francisco, California, United States
Leadership
Employees
- Alex Milowski - Chief Technology Officer (LinkedIn)